Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging
Sponsor: Emory University
Terminated
The study was stopped when the original principal investigator moved to a new institution.
Other terminated trials from Emory University
Other Atherosclerosis trials with similar outcome
This PHASE4 trial investigates Atherosclerosis and is currently terminated or withdrawn. Emory University leads this study, which shows 10 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Mar 2022 — Jul 2024 [monthly]
Terminated PHASE4
-
Jan 2022 — Mar 2022 [monthly]
Terminated PHASE4
-
Jan 2021 — Jan 2022 [monthly]
Terminated PHASE4
▶ Show 5 earlier versions
-
Oct 2018 — Jan 2021 [monthly]
Terminated PHASE4
-
Sep 2018 — Oct 2018 [monthly]
Terminated PHASE4
Status: Completed → Terminated
-
Jun 2018 — Sep 2018 [monthly]
Completed PHASE4
-
Mar 2018 — Jun 2018 [monthly]
Completed PHASE4
Status: Enrolling By Invitation → Completed
-
Jan 2017 — Mar 2018 [monthly]
Enrolling By Invitation PHASE4
First recorded
Apr 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Emory University
For direct contact, visit the study record on ClinicalTrials.gov .